The Iliac/SFA/Popliteal Center

Filter Your Results




FDA Approves Phase 1 Trial of Alucent Medical's Natural Vascular Scaffold Therapy

May 16, 2017 -- Alucent Medical, Inc. announced that it has received US Food and Drug Administration (FDA) approval to begin phase 1 human clinical studies of the company'…

QT Vascular and Medtronic Enter Into Asset Purchase Option Agreement for the Chocolate PTA Catheter

May 12, 2017 -- QT Vascular Ltd. announced that it has entered into an asset purchase option agreement with Medtronic for the acquisition of QT Vascular's non -- drug-coat…

DANCE Trial Investigates Dexamethasone Infusion to Enhance Femoropopliteal Revascularization

May 11, 2017 -- The Society for Cardiovascular Angiography and Interventions (SCAI) announced that Ehrin J. Armstrong, MD, presented results from an analysis of inflammat…

Introducing Serration Technology

Peter A. Schneider, MD

May 2017— We have had

The Serranator® Alto PTA Serration Balloon Catheter

May 2017—The Serranator® Alto PTA Serration Balloon Catheter (Figure 1) is an over-the-wire balloon dilatation catheter designed to perform percutan

Ask the Experts: What Is Your Approach to Vessel Prep?

With J.A. Mustapha, MD, and Andrew Holden, MBChB, FRANZCR, EBIR

May 2017— J.A. Mustapha, MD Director, Cardiovascular Catheterization Laboratories Metro Health Hospital Wyoming, Michigan Clinical Assistant Professor of Medicine Michigan Stat…


May 2017—The PRELUDE Study (PRospective Study for the TrEatment of Atherosclerotic Lesions in the Superficial Femoral Artery and/or Popliteal Artery Using the Serranator DevicE) is a s…

Data-Based Approach to Managing Femoropopliteal In-Stent Restenosis

Marianne Brodmann, MD

May 2017—Peripheral artery disease (PAD) is a growing health concern worldwide; an estimated 200 million patients are affected by PAD, and the number continues to grow.1 Endovascular i…




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.